Publications by authors named "Fatih Tay"

Claim this Profile
A
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.
Fatih Gürler, Fatih Tay, Zehra Sucuoğlu İşleyen, Tahir Yerlikaya, Engin Hendem

Cancer Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer.
Hasan Cagri Yildirim, Mustafa Buyukkor, Gözde Kavgaci, Buket Şahin Celik, Kadriye Bir Yucel, Fatih Tay

Medicine (Baltimore)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Efficiency of Induction and Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer.
Mustafa Buyukkor, Fatih Tay, Aziz Kurtulus, Ozturk Ates

J Coll Physicians Surg Pak· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Combined Chemotherapy Regimens with Bevacizumab in Platinum-sensitive Ovarian Cancers.
Fatih Tay, Mustafa Buyukkor, Ozturk Ates

J Coll Physicians Surg Pak· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Importance of Combined Use of MELD Scores and SII in Hepatic Visceral Crisis in Patients with Solid Tumours.
Fatih Tay, Mustafa Buyukkor, Ayse Ocak Duran

J Coll Physicians Surg Pak· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Markers after Hepatic Function Impairment in Patients with Pancreatic Adenocarcinoma.
Mustafa Buyukkor, Fatih Tay, Cengiz Karacin, Ayse Ocak Duran

J Coll Physicians Surg Pak· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences of the combined use of Favipiravir in patients using Lorlatinib and Brigatinib.
Mustafa Buyukkor, Fatih Tay, Ozturk Ates

J Oncol Pharm Pract· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis